Record Information |
---|
Version | 1.0 |
---|
Created at | 2020-04-17 18:37:45 UTC |
---|
Updated at | 2020-11-18 16:38:42 UTC |
---|
CannabisDB ID | CDB004797 |
---|
Secondary Accession Numbers | Not Available |
---|
Cannabis Compound Identification |
---|
Common Name | Cysteinylglycine |
---|
Description | Cysteinylglycine, also known as CG or cys-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. As this dipeptidase also hydrolyzes the glutathione metabolite cysteinylglycine, the therapeutic association of imipenem and cilastatin causes plasma levels of cysteinylglycine to increase significantly, while cysteine levels are decreased and homocysteine levels are unaffected. Cysteinylglycine is a naturally occurring dipeptide composed of cysteine and glycine. Imipenem (thienamycin formamidine) is a broad-spectrum beta-lactam antibiotic, always used in combination with cilastatin in order to avoid the premature breakdown of imipenem by renal tubular dipeptidase. It is derived from the breakdown of glutathione (a tripeptide). Cysteinylglycine is a very strong basic compound (based on its pKa). Cysteinylglycine exists in all living species, ranging from bacteria to humans. The damage process seems to be related to an overproduction of oxygen reactive species inducing an oxidative perturbation with an increase in some oxidized forms (disulfides and protein mixed disulfides) and a decrease in free thiols (PMID: 15895891 ). Outside of the human body, Cysteinylglycine has been detected, but not quantified in, several different foods, such as garlics, sweet rowanberries, butternut squash, common oregano, and pepper (c. frutescens). This could make cysteinylglycine a potential biomarker for the consumption of these foods. Cysteinylglycine, with regard to humans, has been linked to the inborn metabolic disorder phenylketonuria. Therefore, antibiotic treatment using imipenem-cilastatin induces important metabolic changes that should not remain unrecognized (PMID: 15843241 ). In plasma, cysteinylglycine is in a reduced, oxidized, and protein-bound form (aminothiol) and interacts via redox and disulphide exchange reactions in a dynamic system referred to as redox thiol status (PMID: 8642471 ). The detrimental effect on embryo quality of a high homocysteine (Hcy) concentration in the ejaculate and in the follicular fluid is intriguing and may suggest that Hcy is inversely associated with fertility outcome (PMID: 16556671 ). Cysteinylglycine is expected to be in Cannabis as all living plants are known to produce and metabolize it. |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
CG | ChEBI | Cys-gly | ChEBI | N-L-Cysteinylglycine | ChEBI | L-Cysteinylglycine | Kegg | N-Cysteinyl glycine | HMDB | N-Cysteinyl-glycine | HMDB | N-L-Cysteinyl-glycine | HMDB | Cysteinyl-glycine | HMDB | C-g Dipeptide | HMDB | CG Dipeptide | HMDB | Cysteine glycine dipeptide | HMDB | Cysteine-glycine dipeptide | HMDB | L-Cys-gly | HMDB | N-Cysteinylglycine | HMDB | Cysteinylglycine | ChEBI |
|
---|
Chemical Formula | C5H10N2O3S |
---|
Average Molecular Weight | 178.21 |
---|
Monoisotopic Molecular Weight | 178.0412 |
---|
IUPAC Name | 2-[(2R)-2-amino-3-sulfanylpropanamido]acetic acid |
---|
Traditional Name | Cys-Gly |
---|
CAS Registry Number | 19246-18-5 |
---|
SMILES | N[C@@H](CS)C(=O)NCC(O)=O |
---|
InChI Identifier | InChI=1S/C5H10N2O3S/c6-3(2-11)5(10)7-1-4(8)9/h3,11H,1-2,6H2,(H,7,10)(H,8,9)/t3-/m0/s1 |
---|
InChI Key | ZUKPVRWZDMRIEO-VKHMYHEASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Cysteine or derivatives
- Alpha-amino acid or derivatives
- Amino acid or derivatives
- Amino acid
- Carboxamide group
- Secondary carboxylic acid amide
- Alkylthiol
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Primary aliphatic amine
- Primary amine
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Amine
- Organopnictogen compound
- Organic oxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Disposition | Route of exposure: Source: Biological location: |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | logP | Not Available | Not Available |
|
---|
Predicted Properties | [] |
---|
Spectra |
---|
EI-MS/GC-MS | Type | Description | Splash Key | View |
---|
GC-MS | Cysteinylglycine, 3 TMS, GC-MS Spectrum | splash10-00di-2980000000-043097e8f1f3f47ff51f | Spectrum | GC-MS | Cysteinylglycine, non-derivatized, GC-MS Spectrum | splash10-00di-9440000000-ff8b27f3afc92193d83a | Spectrum | GC-MS | Cysteinylglycine, non-derivatized, GC-MS Spectrum | splash10-00di-2980000000-043097e8f1f3f47ff51f | Spectrum | Predicted GC-MS | Cysteinylglycine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-004i-9200000000-bae23059b39c80a574a5 | Spectrum | Predicted GC-MS | Cysteinylglycine, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-006t-8920000000-1b3a6e358d6996916b0e | Spectrum | Predicted GC-MS | Cysteinylglycine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TMS_1_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Cysteinylglycine, TBDMS_1_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
---|
MS/MS | Type | Description | Splash Key | View |
---|
MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-004i-9700000000-6fba6043a24b724b037e | 2017-09-14 | View Spectrum | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-9000000000-50e069074067c9f120bd | 2021-09-20 | View Spectrum | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-004i-9100000000-ab3327c5b13829ea6d35 | 2021-09-20 | View Spectrum | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-004i-9700000000-9021340a904a56f317cc | 2021-09-20 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-004i-5900000000-b9a1082799c427caf10b | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-004i-9200000000-2b99992e97c6ecb4567b | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a6u-9000000000-a8b591f7522fe16637fb | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-2900000000-0173b5cf52bb61095c3a | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00gl-7900000000-f8dc26c3e8b8ec327fc4 | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0kh9-9100000000-410b0cc1b5e3f850b505 | 2015-09-15 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0096-5900000000-55967cd7162376aa6fa2 | 2021-09-22 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00di-9200000000-5aab410f2c44502defce | 2021-09-22 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00di-9000000000-e0ae26ebba3eeba905da | 2021-09-22 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-056r-9400000000-1878c834f39272d5af42 | 2021-09-23 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-056r-9100000000-0899c0bce2addb667ccb | 2021-09-23 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-9000000000-05f619b00f6286d67d21 | 2021-09-23 | View Spectrum |
|
---|
NMR | Not Available |
---|
Pathways |
---|
Pathways | Name | SMPDB/Pathwhiz | KEGG | Glutathione Metabolism | | | Glutathione Synthetase Deficiency | | Not Available | 5-Oxoprolinuria | | Not Available | Gamma-Glutamyltransferase Deficiency | | Not Available | 5-oxoprolinase deficiency | | Not Available |
|
---|
Protein Targets |
---|
Enzymes | |
---|
Transporters | Not Available |
---|
Metal Bindings | |
---|
Receptors | |
---|
Transcriptional Factors | Not Available |
---|
Concentrations Data |
---|
| Not Available |
---|
External Links |
---|
HMDB ID | HMDB0000078 |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FoodDB ID | FDB021891 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 388596 |
---|
KEGG Compound ID | C01419 |
---|
BioCyc ID | CYS-GLY |
---|
BiGG ID | 1445980 |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 5134 |
---|
PubChem Compound | 439498 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 4047 |
---|
References |
---|
General References | - Giustarini D, Lorenzini S, Rossi R, Chindamo D, Di Simplicio P, Marcolongo R: Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol. 2005 Mar-Apr;23(2):205-12. [PubMed:15895891 ]
- Badiou S, Bellet H, Lehmann S, Cristol JP, Jaber S: Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment. Clin Chem Lab Med. 2005;43(3):332-4. doi: 10.1515/CCLM.2005.057. [PubMed:15843241 ]
- Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM: Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system. J Nutr. 1996 Apr;126(4 Suppl):1281S-4S. doi: 10.1093/jn/126.suppl_4.1281S. [PubMed:8642471 ]
- Ebisch IM, Peters WH, Thomas CM, Wetzels AM, Peer PG, Steegers-Theunissen RP: Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Hum Reprod. 2006 Jul;21(7):1725-33. doi: 10.1093/humrep/del081. Epub 2006 Mar 23. [PubMed:16556671 ]
|
---|